Andere talen Titan Pharmaceuticals, Inc.

Aandelen

TTNP

US8883147055

Vertraagde tijd Nasdaq Andere beurzen 17:10:32 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6,7 ^USD	-0,07%		-3,87%	-18,79%

01/04	Titan Pharmaceuticals, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
26/01	Titan Pharmaceuticals voldoet weer aan de Nasdaq-noteringsregel	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Titan Pharmaceuticals : Non-Reliance on Previously Issued Financial Report - Form 8-K	01/04
Titan Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Titan Pharmaceuticals : Private Placement - Form 8-K	21/03
Titan Pharmaceuticals Regains Compliance With Nasdaq Listing Rule	26/01
Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria	25/01
Titan Pharmaceuticals, Inc. Announces Resignation of Brian Crowley as Senior Vice President, Finance and Administration, Effective February 2, 2024	18/01
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio - December 28, 2023	29/12
Titan Pharmaceuticals to Implement 1-for-20 Reverse Stock Split	29/12
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio	28/12
Titan Pharmaceuticals: Q3 Earnings Snapshot	15/11
Titan Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Titan Pharmaceuticals, Inc. Announces Board Changes	16-10-23
Titan Pharmaceuticals Appoints New Chairman of the Board	16-10-23
Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors	16-10-23
Titan Pharmaceuticals, Inc. Announces Board Resignations	19-09-23
Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock	18-09-23
Titan Pharmaceuticals, Inc. announced that it expects to receive $9.5 million in funding from Sire Group Ltd	13-09-23
TITAN PHARMACEUTICALS : UNAUDITED PRO FORMA CONDENSED FINANCIAL INFORMATION - Form 8-K	08-09-23
Fedson, Inc. completed the acquisition of Certain ProNeura Assets of Titan Pharmaceuticals, Inc..	01-09-23
Titan Pharmaceuticals: Q2 Earnings Snapshot	15-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Titan Pharmaceuticals, Inc.

Aandelen

TTNP

US8883147055

Andere talen

Filters